[HTML][HTML] Safety and feasibility of fan therapy for dyspnea: a scoping review

T Sato, S Taito, Y Nakashima, K Sakai, J Kako - Cureus, 2023 - ncbi.nlm.nih.gov
Fan therapy is a non-pharmacological approach useful in terminally ill patients that relieves
dyspnea by directing a fan to blow air on one side of the patient's face. To date, there has …

Self-management interventions for people with pulmonary fibrosis: a scoping review

JYT Lee, G Tikellis, L Dowman… - European …, 2023 - Eur Respiratory Soc
Background The most effective method for encouraging self-management in individuals with
pulmonary fibrosis (PF) is unclear. This review aimed to identify common self-management …

Treatment of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis: A position statement from the Thoracic Society of Australia and New Zealand 2023 …

JA Mackintosh, G Keir, LK Troy, AE Holland… - …, 2024 - Wiley Online Library
Idiopathic pulmonary fibrosis (IPF) is a progressive disease leading to significant morbidity
and mortality. In 2017 the Thoracic Society of Australia and New Zealand (TSANZ) and Lung …

Validation of a Novel Clinical Dyspnea Scale–A Retrospective Pilot Study

M Kalluri, Y Cui, T Wang… - American Journal of …, 2024 - journals.sagepub.com
Objective: to e xamine the validity of a novel dyspnea scale, Edmonton Dyspnea Inventory in
idiopathic pulmonary fibrosis (IPF). Methods: Edmonton Dyspnea Inventory (EDI), is a …

Patient-centered care in pulmonary fibrosis: access, anticipate, and act

DE Hofman, T Magrì, CC Moor, L Richeldi… - Respiratory …, 2024 - Springer
Comprehensive care integrates individual patient needs and is highly valued for patients
with pulmonary fibrosis (PF). The importance of a patient-centered care approach is rooted …

Dyspnea and dyspnea-associated anxiety in the ICU patient population: a narrative review for CL psychiatrists

Y Sher, N Desai, J Sole, MP D'souza - Journal of the Academy of …, 2024 - Elsevier
Background Consultation-liaison psychiatrists frequently address dyspnea in intensive care
unit (ICU) patients. Dyspnea is common in this patient population, but is frequently …

[HTML][HTML] Chronic breathlessness in fibrotic interstitial lung diseases—patient centered assessment and management in outpatient settings

M Kalluri - Annals of Palliative Medicine, 2024 - apm.amegroups.org
Chronic breathlessness (CB) or dyspnea is prevalent in fibrotic interstitial lung diseases (F-
ILD). It is the main driver of a poor health-related quality of life (HRQOL). Timely and …

Challenges of symptom management in interstitial lung disease: dyspnea, cough and fatigue

A Pascoe, AE Holland, N Smallwood - Expert Review of …, 2025 - Taylor & Francis
Introduction Interstitial lung disease (ILD) is a broad group of conditions characterized by
fibrosis of the lung parenchyma. Idiopathic pulmonary fibrosis (IPF) is the most common …

Dyspnoea relief as an inherent benefit of high flow nasal cannula therapy: A laboratory randomized trial in healthy humans

C Bianquis, C Rolland‐Debord, I Rivals… - …, 2024 - Wiley Online Library
Abstract Background and Objective Persistent dyspnoea is a public health issue for which
the therapeutic arsenal is limited. This study tested high‐flow nasal cannula therapy (HFNT) …

Effects of Self-Management Interventions in People With Interstitial Lung Disease

SFD Santos, A Marques, P Rebelo, D Brooks… - Respiratory …, 2024 - liebertpub.com
BACKGROUND: People with interstitial lung disease (ILD) want to actively manage their
condition; however, the effects of self-management interventions (SMIs) in this population …